vs
PRECISION BIOSCIENCES INC（DTIL）与FrontView REIT, Inc.（FVR）财务数据对比。点击上方公司名可切换其他公司
PRECISION BIOSCIENCES INC的季度营收约是FrontView REIT, Inc.的1.9倍（$34.2M vs $18.2M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs 2.2%，领先56.7%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs 12.0%）
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
DTIL vs FVR — 直观对比
营收规模更大
DTIL
是对方的1.9倍
$18.2M
营收增速更快
DTIL
高出5249.2%
12.0%
净利率更高
DTIL
高出56.7%
2.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $18.2M |
| 净利润 | $20.1M | $400.0K |
| 毛利率 | — | — |
| 营业利润率 | 36.6% | 24.9% |
| 净利率 | 58.9% | 2.2% |
| 营收同比 | 5261.1% | 12.0% |
| 净利润同比 | 213.5% | — |
| 每股收益（稀释后） | $2.62 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTILFVR
| Q1 26 | — | $18.2M | ||
| Q4 25 | $34.2M | $16.5M | ||
| Q3 25 | $13.0K | $16.8M | ||
| Q2 25 | $18.0K | $17.6M | ||
| Q1 25 | $29.0K | $16.2M | ||
| Q4 24 | $638.0K | — | ||
| Q3 24 | $576.0K | $14.5M | ||
| Q2 24 | $49.9M | — |
净利润DTILFVR
| Q1 26 | — | $400.0K | ||
| Q4 25 | $20.1M | $-4.1M | ||
| Q3 25 | $-21.8M | $4.0M | ||
| Q2 25 | $-23.5M | $-2.9M | ||
| Q1 25 | $-20.6M | $-833.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-16.4M | $-2.4M | ||
| Q2 24 | $32.7M | — |
营业利润率DTILFVR
| Q1 26 | — | 24.9% | ||
| Q4 25 | 36.6% | — | ||
| Q3 25 | -158976.9% | — | ||
| Q2 25 | -121538.9% | — | ||
| Q1 25 | -76248.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -3693.6% | — | ||
| Q2 24 | 48.4% | — |
净利率DTILFVR
| Q1 26 | — | 2.2% | ||
| Q4 25 | 58.9% | -24.9% | ||
| Q3 25 | -167476.9% | 23.9% | ||
| Q2 25 | -130666.7% | -16.5% | ||
| Q1 25 | -70913.8% | -5.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -2851.6% | -16.7% | ||
| Q2 24 | 65.6% | — |
每股收益（稀释后）DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | $2.62 | $-0.19 | ||
| Q3 25 | $-1.84 | $0.19 | ||
| Q2 25 | $-2.13 | $-0.16 | ||
| Q1 25 | $-2.21 | $-0.06 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.25 | — | ||
| Q2 24 | $4.67 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.6M | $9.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $92.2M | $514.2M |
| 总资产 | $154.4M | $869.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DTILFVR
| Q1 26 | — | $9.3M | ||
| Q4 25 | $115.6M | $13.5M | ||
| Q3 25 | $44.9M | $19.6M | ||
| Q2 25 | $62.2M | $8.4M | ||
| Q1 25 | $77.2M | $3.3M | ||
| Q4 24 | $86.3M | — | ||
| Q3 24 | $101.2M | — | ||
| Q2 24 | $123.6M | — |
总债务DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | — | $314.3M | ||
| Q3 25 | — | $307.1M | ||
| Q2 25 | — | $316.9M | ||
| Q1 25 | — | $310.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益DTILFVR
| Q1 26 | — | $514.2M | ||
| Q4 25 | $92.2M | $391.2M | ||
| Q3 25 | $16.6M | $385.2M | ||
| Q2 25 | $34.1M | $369.9M | ||
| Q1 25 | $49.3M | $324.7M | ||
| Q4 24 | $56.4M | — | ||
| Q3 24 | $64.9M | $1.0K | ||
| Q2 24 | $74.7M | — |
总资产DTILFVR
| Q1 26 | — | $869.8M | ||
| Q4 25 | $154.4M | $854.4M | ||
| Q3 25 | $93.5M | $846.8M | ||
| Q2 25 | $108.9M | $856.5M | ||
| Q1 25 | $124.4M | $860.8M | ||
| Q4 24 | $136.4M | — | ||
| Q3 24 | $153.3M | $1.0K | ||
| Q2 24 | $165.8M | — |
负债/权益比DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.80× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.96× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-11.3M | — |
| 自由现金流率自由现金流/营收 | -32.9% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | -0.56× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | $-11.3M | $42.1M | ||
| Q3 25 | $-15.3M | $8.3M | ||
| Q2 25 | $-20.3M | $9.3M | ||
| Q1 25 | $-19.1M | $8.1M | ||
| Q4 24 | $-58.4M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $-14.9M | — |
自由现金流DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | $-11.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.3M | — | ||
| Q1 25 | $-19.1M | — | ||
| Q4 24 | $-58.7M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-14.9M | — |
自由现金流率DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | -32.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -112627.8% | — | ||
| Q1 25 | -65917.2% | — | ||
| Q4 24 | -9199.8% | — | ||
| Q3 24 | -1033.2% | — | ||
| Q2 24 | -29.9% | — |
资本支出强度DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 220.7% | — | ||
| Q4 24 | 39.2% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 0.1% | — |
现金转化率DTILFVR
| Q1 26 | — | — | ||
| Q4 25 | -0.56× | — | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
